Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESTIS trial: Early stop of anakinra guided by IL-18 in children with systemic juvenile idiopathic arthritis
NL-OMON60408Phase 4Not yet recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of anakinra in systemic juvenile idiopathic arthritis (SJIA) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Total number of anakinra injections in first year. Planned start Oct 2016; status: not yet recruiting.
02
Drugs
anakinra
03
Conditions
systemic juvenile idiopathic arthritis (SJIA)
Beyond the preview
Go deeper on NL-OMON60408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60408.